Active	Status	Sponsor type	Region	Phase	Filter
4 Active 0 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Sanchez, Eduardo Vilar
NCT05112822: Testing Obeticholic Acid (OCA) for Familial Adenomatous Polyposis (FAP)	Not yet recruiting	2a	80	US	Obeticholic Acid, Ocaliva, Placebo	M.D. Anderson Cancer Center	Familial Adenomatous Polyposis	02/24	02/24
NCT05411718: A Phase IIa Randomized, Double-Blinded Clinical Trial of Naproxen or Aspirin for Cancer Immune Interception in Lynch Syndrome	Recruiting	2	40	US	Naproxen, Aspirin	M.D. Anderson Cancer Center, National Institutes of Health (NIH), National Cancer Institute (NCI)	T Cells, Colorectal Cancer, Lynch Syndrome	11/25	11/25
NCT02048735: Naproxen for Lynch Syndrome	Recruiting	1	60	US	Naproxen, Placebo, Sugar Pill, Endoscopy, Phone Calls	M.D. Anderson Cancer Center, National Cancer Institute (NCI)	Gastrointestinal Diseases	01/21
NCT02832245: Computerized Registry of Patients With Venous Thromboembolism (RIETE)	Recruiting	N/A	120000	Europe, Japan, US, RoW		Manuel Monreal	Venous Thromboembolism	12/26	12/27